Macrophage Secretory Products Induce an Inflammatory Phenotype in Hepatocytes
Overview
Authors
Affiliations
Aim: To investigate the influence of macrophages on hepatocyte phenotype and function.
Methods: Macrophages were differentiated from THP-1 monocytes via phorbol myristate acetate stimulation and the effects of monocyte or macrophage-conditioned medium on HepG2 mRNA and protein expression determined. The in vivo relevance of these findings was confirmed using liver biopsies from 147 patients with hepatitis C virus (HCV) infection.
Results: Conditioned media from macrophages, but not monocytes, induced a transient morphological change in hepatocytes associated with upregulation of vimentin (7.8 ± 2.5-fold, P = 0.045) and transforming growth factor (TGF)-β1 (2.6 ± 0.2-fold, P < 0.001) and downregulation of epithelial cadherin (1.7 ± 0.02-fold, P = 0.017) mRNA expression. Microarray analysis revealed significant upregulation of lipocalin-2 (17-fold, P < 0.001) and pathways associated with inflammation, and substantial downregulation of pathways related to hepatocyte function. In patients with chronic HCV, real-time polymerase chain reaction and immunohistochemistry confirmed an increase in lipocalin-2 mRNA (F0 1.0 ± 0.3, F1 2.2 ± 0.2, F2 3.0 ± 9.3, F3/4 4.0 ± 0.8, P = 0.003) and protein expression (F1 1.0 ± 0.5, F2 1.3 ± 0.4, F3/4 3.6 ± 0.4, P = 0.014) with increasing liver injury. High performance liquid chromatography-tandem mass spectrometry analysis identified elevated levels of matrix metalloproteinase (MMP)-9 in macrophage-conditioned medium, and a chemical inhibitor of MMP-9 attenuated the change in morphology and mRNA expression of TGF-β1 (2.9 ± 0.2 vs 1.04 ± 0.1, P < 0.001) in macrophage-conditioned media treated HepG2 cells. In patients with chronic HCV infection, hepatic mRNA expression of CD163 (F0 1.0 ± 0.2, F1/2 2.8 ± 0.3, F3/4 5.3 ± 1.0, P = 0.001) and MMP-9 (F0 1.0 ± 0.4, F1/2 2.8 ± 0.3, F3/4 4.1 ± 0.8, P = 0.011) was significantly associated with increasing stage of fibrosis.
Conclusion: Secreted macrophage products alter the phenotype and function of hepatocytes, with increased expression of inflammatory mediators, suggesting that hepatocytes actively participate in liver injury.
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI.
Stern S, Wang H, Sadrieh N Cells. 2023; 12(11).
PMID: 37296597 PMC: 10253021. DOI: 10.3390/cells12111476.
In Vitro Models for Studying Chronic Drug-Induced Liver Injury.
Donato M, Gallego-Ferrer G, Tolosa L Int J Mol Sci. 2022; 23(19).
PMID: 36232728 PMC: 9569683. DOI: 10.3390/ijms231911428.
Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury.
Tasnim F, Huang X, Lee C, Ginhoux F, Yu H Front Toxicol. 2022; 3:605392.
PMID: 35295156 PMC: 8915912. DOI: 10.3389/ftox.2021.605392.
Zhao S, Li W, Fu N, Kong L, Zhang Q, Han F Exp Ther Med. 2020; 20(6):228.
PMID: 33149783 PMC: 7604741. DOI: 10.3892/etm.2020.9358.
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats .
Khurana P, Yadati T, Goyal S, Dolas A, Houben T, Oligschlaeger Y Biomolecules. 2019; 9(5).
PMID: 31060228 PMC: 6571693. DOI: 10.3390/biom9050171.